Creative Medical Technology Holdings Inc
CELZ1.930USD
+0.150+8.43%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
4.98MMarket Cap
LossP/E TTM
More Details of Creative Medical Technology Holdings Inc Company
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Creative Medical Technology Holdings Inc Info
Ticker SymbolCELZ
Company nameCreative Medical Technology Holdings Inc
IPO dateMay 01, 2009
CEOWarbington (Timothy)
Number of employees4
Security typeOrdinary Share
Fiscal year-endMay 01
Address211 E. Osborn Rd.
CityPHOENIX
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code85012
Phone14803992822
Websitehttps://creativemedicaltechnology.com/
Ticker SymbolCELZ
IPO dateMay 01, 2009
CEOWarbington (Timothy)
Company Executives of Creative Medical Technology Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
0.74%
Geode Capital Management, L.L.C.
0.67%
Creative Medical Health, Inc.
0.65%
DRW Securities, LLC
0.43%
Warbington (Timothy)
0.35%
Other
97.16%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
0.74%
Geode Capital Management, L.L.C.
0.67%
Creative Medical Health, Inc.
0.65%
DRW Securities, LLC
0.43%
Warbington (Timothy)
0.35%
Other
97.16%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.44%
Investment Advisor/Hedge Fund
0.67%
Corporation
0.65%
Individual Investor
0.36%
Research Firm
0.03%
Other
96.85%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
27
72.58K
11.84%
--
2025Q3
29
72.58K
11.88%
+776.00
2025Q2
25
71.80K
10.72%
-129.79K
2025Q1
23
201.59K
4.41%
+89.66K
2024Q4
25
29.86K
7.67%
-49.38K
2024Q3
28
77.15K
11.92%
-653.00
2024Q2
30
77.93K
20.77%
-35.91K
2024Q1
32
113.90K
14.79%
-86.68K
2023Q4
34
27.41K
16.84%
+6.21K
2023Q3
38
90.73K
17.10%
+463.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
25.87K
0.74%
+8.24K
+46.74%
Sep 30, 2025
Geode Capital Management, L.L.C.
23.26K
0.67%
+2.38K
+11.40%
Sep 30, 2025
Creative Medical Health, Inc.
22.70K
0.65%
--
--
Oct 29, 2025
DRW Securities, LLC
15.10K
0.43%
+15.10K
--
Sep 30, 2025
Warbington (Timothy)
12.21K
0.35%
--
--
Oct 29, 2025
Osaic Holdings, Inc.
1.13K
0.03%
--
--
Sep 30, 2025
Edward Jones
1.00K
0.03%
+1.00K
--
Sep 30, 2025
Finger (Michael H.)
351.00
0.01%
--
--
Oct 29, 2025
Fidelity Management & Research Company LLC
200.00
0.01%
+200.00
--
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
